VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $608,827 | +19.4% | 18,820 | +5.8% | 0.06% | +11.1% |
| Q4 2022 | $510,005 | -72.6% | 17,795 | -73.8% | 0.05% | -69.5% |
| Q2 2022 | $1,858,000 | -64.9% | 67,845 | -50.9% | 0.18% | -55.9% |
| Q1 2022 | $5,300,000 | +16.3% | 138,195 | -2.9% | 0.40% | +25.3% |
| Q4 2021 | $4,559,000 | -6.2% | 142,325 | -13.7% | 0.32% | -19.6% |
| Q3 2021 | $4,861,000 | -12.9% | 164,965 | +0.5% | 0.40% | -9.1% |
| Q2 2021 | $5,580,000 | +44.1% | 164,215 | +37.8% | 0.44% | +37.3% |
| Q1 2021 | $3,873,000 | -48.2% | 119,180 | -42.5% | 0.32% | -52.4% |
| Q4 2020 | $7,470,000 | -8.4% | 207,385 | -0.5% | 0.67% | -21.5% |
| Q3 2020 | $8,159,000 | -23.9% | 208,360 | -28.7% | 0.85% | -23.3% |
| Q2 2020 | $10,718,000 | – | 292,210 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |